Related Experiment Videos
[Intervention studies on elderly hypertensive patients in Japan]
Fumio Saito1, Atsuhiko Takahashi, Toshio Kushiro
1Department of Cardiology, Surugadai Nihon University Hospital.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|June 14, 2005
Summary
Antihypertensive therapy benefits elderly patients with hypertension, as shown in Western studies. Recent Japanese trials like JATOS and COPE will offer new evidence for this population.
Area of Science:
- Gerontology
- Cardiovascular Medicine
- Clinical Pharmacology
Context:
- Elderly hypertensive patients represent a significant population with unique therapeutic considerations.
- Western clinical trials have established the efficacy of various antihypertensive drug classes in this demographic.
- Limited intervention studies have been reported in Japan, highlighting a gap in regional evidence.
Purpose:
- To review and summarize existing intervention studies on antihypertensive therapy in elderly hypertensive patients.
- To compare findings from Western countries with the limited data available from Japan.
- To highlight recent and ongoing Japanese studies that will contribute new evidence.
Summary:
- Western studies demonstrate the benefits of diuretics, beta-blockers, calcium antagonists, ACE inhibitors, and ARBs in elderly hypertension.
- Only the NICS-EH and JATE studies have been reported in Japan for this patient group.
- Recent Japanese trials (JATOS, COPE, CASE-J, HOMED-BP, VALISH) are expected to provide crucial new data.
Impact:
- Informing clinical practice guidelines for managing hypertension in elderly populations globally.
- Identifying potential regional differences in treatment response and efficacy.
- Guiding future research priorities in geriatric cardiovascular medicine.